RFK Jr. promotes peptides. Now the FDA weighs easing limits on the unproven chemicals The Peptide Moment: How FDA's Regulatory Reversal Creates Risk and Opportunity for Venture Capital and Private Equity Guidepost Solutions The Emerging Risk of Peptides in Supplements LegitScript The Food and Drug Administration will hold a meeting this summer to consider easing restrictions on more than a half dozen peptide injections, a group of unapproved therapies that have become popular